MANH:NASDAQManhattan Associates, Inc. Analysis
Data as of 2026-08-24 - not real-time
$214.56
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Manhattan Associates, Inc. is priced at $214.56 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 38.5%. Relative strength is 73.6 — overbought — and the MACD signal is bullish. Price has been bracketed by support at $153.91 and resistance at $215.38.
On valuation the read is overvalued — earnings multiple of 61.3 versus a 35.2 sector average, above the peer group. Consensus targets land 3.5% below where the shares trade now. Revenue is growing at 9.3% on a 18.7% profit margin.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 71.5%, a beta of 0.34 and a maximum drawdown of 44.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
On valuation the read is overvalued — earnings multiple of 61.3 versus a 35.2 sector average, above the peer group. Consensus targets land 3.5% below where the shares trade now. Revenue is growing at 9.3% on a 18.7% profit margin.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 71.5%, a beta of 0.34 and a maximum drawdown of 44.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
In late July 2026, Manhattan Associates reported second-quarter results showing revenue of US$297.Shares of supply chain software provider Manhattan Associates NASDAQ:MANH jumped 22.Seeking Alpha25dManhattan Associates skyrockets 28% after bumper results, upgraded guidanceManhattan Associates’ MANH...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- RSI at 73.6 signals overbought conditions
- Trading above the 200-day average of 156.08
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- RSI at 73.6 signals overbought conditions
- P/E of 61.3 versus sector average of 35.2
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 61.3 versus sector average of 35.2
- Profit margin of 18.7% is healthy
- Return on equity of 96.4%
Key Metrics & Analysis
Financial Health
Revenue Growth9.30%
Profit Margin18.67%
P/E Ratio61.3
ROE96.38%
ROA24.45%
Debt/Equity34.21
P/B Ratio79.4
Op. Cash Flow$414.9M
Free Cash Flow$321.1M
Industry P/E35.2
Technical Analysis
TrendBullish
RSI73.6
Support$153.91
Resistance$215.38
MA 20$193.84
MA 50$165.78
MA 200$156.08
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair Value$106.64
Target Price$207.00
Upside/Downside-3.52%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.34
Volatility71.52%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.